论文部分内容阅读
目的:探讨分析缩宫素与米索前列醇对产后出血的治疗效果。方法:选取我院2011年1月—2015年1月收治的产后出血患者120例的临床资料进行回顾性分析,将其随机分为观察组和对照组,各60例。对照组患者采取宫缩素治疗,观察组患者采取米索前列醇治疗。观察两组患者的治疗效果。结果:经过治疗后,观察组患者的第三产程时间以及产后2h、12h以及24h之内的出血情况均优于对照组,两组之间的比较具有显著差异(P<0.05),具统计学意义。结论:对产后出血患者采取米索前列醇进行治疗,具有良好的质量效果,能很大程度降低患者的出血量,缩短患者的第三产程时间,值得在临床上推广应用。
Objective: To investigate the effect of oxytocin and misoprostol on postpartum hemorrhage. Methods: The clinical data of 120 patients with postpartum hemorrhage treated in our hospital from January 2011 to January 2015 were retrospectively analyzed. They were randomly divided into observation group and control group, with 60 cases in each group. Patients in the control group were treated with orpirin, while patients in the observation group were treated with misoprostol. Observed the treatment effect of two groups of patients. Results: After treatment, the duration of the third stage of labor and bleeding within 2h, 12h and 24h after birth in the observation group were better than those in the control group, with significant differences (P <0.05) between the two groups with statistical significance significance. Conclusion: The treatment of misoprostol for postpartum hemorrhage patients has a good quality effect, which can greatly reduce the amount of bleeding and shorten the third stage of labor in patients. It is worth popularizing and applying in clinic.